Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-complex protein 10A homolog 2 (TCP10L) is a liver- and testis-specific nuclear protein that functions as a transcription factor possessing a typical leucine zipper motif. It acts as a transcriptional corepressor, significantly inhibiting expression of reporter genes and involved in the negative regulation of transcription by RNA polymerase II[1][2][3][4]. TCP10L is also reported to act as a tumor suppressor in hepatocellular carcinoma cells, with its expression found downregulated in liver tumor tissues[1][3][5]. The protein is encoded by the TCP10L gene, located on human chromosome 21q22.11, and consists of 215 amino acids[1][2][4]. No approved therapeutics or established small molecule inhibitors/modulators are documented for TCP10L to date, and it is not currently recognized as a direct therapeutic target in drug discovery databases[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-complex protein 10A homolog 2 (TCP10L).